Intercept Pharmaceuticals | ICPT - Ebitda



Ebitda Alterar Data
Acadia Pharmaceuticals USD 35.76M 447K 2025-09
Alnylam Pharmaceuticals USD 145.22M 236.56M 2025-12
Amarin USD 12.54M 28.57M 2025-06
Amgen USD 5.14B 775M 2025-12
Arrowhead Research USD 64.2M 223.53M 2025-09
AstraZeneca USD 5.67B 1.29B 2026-03
Biogen USD 649.7M 76.5M 2026-03
Bristol-Myers Squibb USD 2.88B 1.36B 2025-12
Eli Lilly USD 12.14B 4.26B 2025-12
Esperion Therapeutics USD -9.93M 24.99M 2025-09
Galectin Therapeutics USD -7.42M 819K 2021-12
Gilead Sciences USD 3.02B 1.01B 2025-12
GlaxoSmithKline GBP 2.77B 1.65B 2026-03
Incyte USD 414.5M 92.42M 2025-12
Ionis Pharmaceuticals USD -200.02M 42.89M 2025-12
Moderna USD -790M 582M 2025-12
Neurocrine Biosciences USD 218.4M 28.3M 2025-12
Novartis USD 5.3B 530M 2026-03
PTC Therapeutics USD -70.99M 91.62M 2025-12
Regeneron Pharmaceuticals USD 1.2B 718.4M 2025-12
Sarepta Therapeutics USD -168.03M 294.45M 2025-09
Vertex Pharmaceuticals USD 1.44B 100.4M 2025-09